About: Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 30 May 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en mayu de 2019 (ast) scientific article published on 30 May 2019 (en) наукова стаття, опублікована 30 травня 2019 (uk)
publication date	wds:Q92413578-DBFF2C81-FEEB-460F-8F3F-23534F13277A
publication date	2019-05-30 00:00:00Z (xsd:dateTime)
cites work	wds:Q92413578-095A0183-9D75-49DF-8351-A8054C2DC035 wds:Q92413578-09FDE1FC-04D9-4B0C-B61B-519EEA979933 wds:Q92413578-0A370749-2D76-4A9B-9435-9B943BB10E54 wds:Q92413578-1CE32B93-9BFC-4F3A-99DB-1EB571E75F1C wds:Q92413578-26FCC218-6DAE-4DD9-AE07-C078D0A5FD1F wds:Q92413578-2B9F9633-F1C8-432E-B1F8-900B8CADE525 wds:Q92413578-39BD0399-707F-4A9F-AF08-B73BFD5A2856 wds:Q92413578-3F657C70-7EF0-41CD-AB53-AB64243CA521 wds:Q92413578-41F20177-EF0B-47C3-B177-35EE7B79697A wds:Q92413578-50DA9D3A-9873-48DE-AFE7-2D2D693E17C8 wds:Q92413578-55C3AE4E-F59D-401D-AEA8-CB72DAC195C1 wds:Q92413578-61414D43-8156-439D-B350-EF2C4671224A wds:Q92413578-6CE9694D-FAB6-40EE-9235-A956369BB11F wds:Q92413578-71FBFD5C-99D5-46FD-A8A6-E88D72C1BFFD wds:Q92413578-83AEE8F0-8EC2-4684-8BB3-18DBBFB98BA4 wds:Q92413578-8AC967C8-2E05-48A5-B47E-4C17AED558A1 wds:Q92413578-8D6AA8EA-6346-4024-96CD-47A49F31A296 wds:Q92413578-9340A1CB-7CD3-4FE5-A8A6-EE8B34880178 wds:Q92413578-A2112224-BF66-45CA-B134-859083BE2969 wds:Q92413578-AAEC9B36-FD05-4BAB-852E-AAA0AD294FD3 wds:Q92413578-B3FE83CE-FDDD-4977-8F95-4B9C76FDC644 wds:Q92413578-C085EA1B-75DA-4B68-891D-98E04B81A1DC wds:Q92413578-C3F71A0A-07F3-4AAA-9303-FA156CF34AE3 wds:Q92413578-CF11C99B-8548-4238-9370-40CDC9CDBD45 wds:Q92413578-CFB8C10F-542D-457E-B958-146C18BF1749 wds:Q92413578-DA05CCF4-49C4-4B0E-839E-A73AD9012323 wds:Q92413578-F7D8F8CF-1FF6-43C5-A32C-2FA12D9A436D
cites work	Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand Long-term persistence of immunity after vaccination of pre-adolescents with low doses of a recombinant hepatitis B vaccine Booster dose vaccination for preventing hepatitis B Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose Long-term efficacy of 10-12 years after being immunized with Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities. Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese rural communities. Efficacy of yeast-derived recombinant hepatitis B vaccine after being used for 12 years in highly endemic areas in China The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy Hepatitis B vaccine by intradermal route in non responder patients: an update The one year effects of three doses of hepatitis B vaccine as a booster in anti-HBs-negative children 11-15 years after primary immunization; China, 2009-2011. Effects of hepatitis B vaccine boosters on anti-HBs-negative children after primary immunization Hepatitis B vaccines: WHO position paper – July 2017 Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine Predictors of Booster Response to Hepatitis B Vaccine at 15 years of age: A Cross-Sectional School-Based Study Hepatitis B vaccine and the need for a booster dose after primary vaccination Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy Determinants of Long-term protection after hepatitis B vaccination in infancy: a meta-analysis Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China. Assessment of Immunization to Hepatitis B Vaccine among Children under Five Years in Rural Areas of Taiz, Yemen Persistence of immunity 18-19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy. Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study [Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014] The efficacy of hepatitis B vaccination program in upper Egypt: Flow cytometry and the evaluation of long term immunogenicity.
author name string	wds:Q92413578-17A33465-D204-4B8B-96E6-4B6B0DADFE01 wds:Q92413578-1AF7ED74-133B-4B3D-A5A2-8F9B1614B0A1 wds:Q92413578-24AA3FD3-BA08-4B6F-81FE-BC0334155ACE wds:Q92413578-24B2DEA3-704F-40EE-96A6-7F4710ECB66D wds:Q92413578-547EFD86-8885-44DB-A877-14BE3AC8EBD5 wds:Q92413578-614FC8C7-BCF7-4742-9086-8B292328B600 wds:Q92413578-7A299F84-A4F1-4F7A-B0F5-93E20A7FD816 wds:Q92413578-9E0A048A-C541-4C89-BA2B-A2C0A110FF44 wds:Q92413578-AB0B628C-F6C5-46BA-8545-368D9AEF730C wds:Q92413578-B6391A8B-08CB-492D-9518-08A22B2CC7B4 wds:Q92413578-DAB97E44-C5E6-4F05-8511-8453C70B2941 wds:Q92413578-E22C1EC7-DEC1-4B67-8D5A-B6CCDB8D4BB3
author name string	Zhao Gao Feng Wang Qi Li Zhi-Wei Wu Yu-Liang Zhao Lu-Lu Pan Xin-Jiang Zhang Jing-Chen Ma Zhi-Yong Hao Hai-Song Zhou Tian-Li Ma Bi-Hua Han
rdfs:label	Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination (en) Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination (nl)
skos:prefLabel	Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination (en) Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination (nl)
name	Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination (en) Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination (nl)
author	wds:Q92413578-3B205EE3-2244-4666-AB0F-B6443091547F
author	Shengli Bi
title	wds:Q92413578-FDF00F8A-7CD9-4F53-A0B2-83D4A7EFE43C
title	Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination (en)
page(s)	wds:Q92413578-BAEFF64E-B42C-4DF5-BF56-4892D39596FC
page(s)	482
instance of	wds:Q92413578-F91EA9C8-B0D5-44DE-AD02-A722EBB139D0
instance of	scholarly article
main subject	wds:Q92413578-3C9FA5D2-1768-4C3A-A82B-8A662051C2F8

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software